Analytical Data
-
Gene name
SDF4
- Application
-
Alternative Names
SDF4;CAB45;45 kDa calcium-binding Protein
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9BRK5
-
Expression Region
37-362aa
-
AA Sequence
RPANHSSTRERVANREENEILPPDHLNGVKLEMDGHLNRGFHQEVFLGKDLGGFDEDAEPRRSRRKLMVIFSKVDVNTDRKISAKEMQRWIMEKTAEHFQEAMEESKTHFRAVDPDGDGHVSWDEYKVKFLASKGHSEKEVADAIRLNEELKVDEETQEVLENLKDRWYQADSPPADLLLTEEEFLSFLHPEHSRGMLRFMVKEIVRDLDQDGDKQLSVPEFISLPVGTVENQQGQDIDDNWVKDRKKEFEELIDSNHDGIVTAEELESYMDPMNEYNALNEAKQMIAVADENQNHHLEPEEVLKYSEFFTGSKLVDYARSVHEEF
-
Molecular Weight
45.4 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SDF4 (Stromal Derived Factor 4) is a chemokine belonging to the CXC family, playing a significant role in immune responses, tissue repair, and inflammation. As research on chemokines advances, SDF4 has gained attention due to its potential implications in various pathological conditions, including cancer, cardiovascular diseases, and autoimmune disorders. The interest in SDF4 is driven by its dual functions in modulating the migration of immune cells and promoting angiogenesis. Understanding the molecular mechanisms of SDF4 has opened new avenues for targeted therapies and novel biomarker development. Recent advancements in recombinant protein technology have enabled the production of SDF4 in sufficient quantities for in-depth functional studies. By generating and characterizing SDF4 recombinant proteins, researchers can investigate its biological activities, receptor interactions, and signaling pathways. This research not only enhances our understanding of SDF4's physiological roles but also its potential applications in clinical therapeutics. Overall, the study of SDF4 recombinant proteins represents a promising frontier in harnessing the therapeutic potential of chemokines for improving human health.











